FCS Joins Oncology Leaders to Help Shape the Future of Cancer Care at FLASCO 2026

FCS leader to share insights on evolving oncology care models and workforce transformation at statewide industry summit

Fort Myers, Fla., April 10, 2026 – Florida Cancer Specialists & Research Institute, LLC (FCS) will join colleagues at the Florida Society of Clinical Oncology (FLASCO) 2026 Spring Congress featuring the Business of Oncology Summit, April 10 – 11 in Orlando.

“Events like the FLASCO Spring Congress provide an important opportunity for oncology leaders to collaborate, share insights, and explore innovative approaches that are shaping the future of cancer care,” said FCS Assistant Managing Physician, David Wenk, MD.

Richard McDonough, MD, director of advocacy & policy, will serve as a panelist on From Traditional Practice Models to a Redefined Oncology Workforce: How Oncology is Being Practiced and Structured Today. Dr. McDonough will also host a fellows and residents reception, which provides the opportunity for oncology fellows and resident physicians with an interest in oncology to network with FLASCO physicians and others. A past president of FLASCO, Dr. McDonough, currently serves on its board of directors.

“As the oncology landscape continues to evolve, it is essential that we adapt how care is delivered, strengthening our workforce, embracing new care models, and ensuring patients continue to receive high-quality, accessible treatment,” said Dr. McDonough.

The Florida Society of Clinical Oncology (FLASCO) is a statewide non-profit organization committed to facilitating and promoting multidisciplinary efforts for oncology practitioners and industry professionals to improve patient care in Florida.